# PURE (PURE Bioscience, Inc.) - SEC EDGAR Financial Statements

> PURE Bioscience, Inc. reported $2.31M in revenue and a net loss of $2.48M for the fiscal year ended July 31, 2026 (up 5.3% year over year), with a 57.3% gross margin and a -90.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/PURE
- Markdown: https://convexityos.com/fundamentals/PURE.md
- SEC CIK: 0001006028
- Reporting currency: USD
- Latest filing period: July 31, 2026
- Last synced: Nov 21, 2026, 05:07 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001006028&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | $2.31M | +5.3% YoY |
| Operating Income | FY 2026 | -$2.08M | -90.0% margin |
| Net Income | FY 2026 | -$2.48M | -107.3% net margin |
| Diluted EPS | FY 2026 | -$0.02 | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jul 31, 2026 | $569K | Total debt: $6.60M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.31M | $2.20M | $1.96M | $1.87M | $1.81M | $3.70M | $6.92M | $1.91M | $1.77M | $1.83M |
| Cost of Revenue | $992K | $899K | $811K | $906K | $853K | $1.85M | $2.90M | $728K | $763K | $760K |
| **Gross Profit** | $1.33M | $1.30M | $1.15M | $971K | $1.00M | $2.08M | $4.02M | $1.18M | $1.01M | $1.07M |
| Research & Development | $332K | $316K | $302K | $297K | $319K | $339K | $322K | $354K | $459K | $779K |
| Selling, General & Admin | $3.08M | $3.26M | $3.98M | $4.30M | $4.05M | $4.05M | $3.69M | $6.42M | $5.24M | $5.23M |
| Total Operating Expenses | $3.41M | $3.58M | $4.34M | $4.91M | $4.72M | $4.39M | $4.02M | $6.77M | $8.82M | $7.84M |
| **Operating Income** | -$2.08M | -$2.27M | -$3.19M | -$3.94M | -$3.72M | -$2.31M | $4.0K | -$5.59M | -$7.04M | -$6.01M |
| **EBITDA** | -$2.08M | -$2.27M | -$3.04M | -$3.83M | -$3.51M | -$2.14M | $196K | -$5.35M | -$6.76M | -$5.73M |
| Interest Expense | $407K | $299K | $155K | $14K | $6.0K | $4.0K | $5.0K | $6.0K | $8.0K | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $1.6K | $1.6K | $1.6K | $1.6K | $1.6K | $1.6K |
| **Net Income** | -$2.48M | -$2.40M | -$3.35M | -$3.96M | -$3.49M | -$2.32M | $4.0K | -$6.55M | -$7.44M | -$6.26M |
| Basic EPS | -$0.02 | -$0.02 | -$0.03 | -$0.04 | -$0.04 | -$0.03 | $0.00 | -$0.09 | -$0.11 | -$0.10 |
| **Diluted EPS** | -$0.02 | -$0.02 | -$0.03 | -$0.04 | -$0.04 | -$0.03 | $0.00 | -$0.09 | -$0.11 | -$0.10 |
| Basic Shares Outstanding | 116.5M | 111.9M | 111.9M | 111.4M | 88.8M | 87.2M | 82.2M | 72.9M | 67.3M | 63.5M |
| Diluted Shares Outstanding | 116.5M | 111.9M | 111.9M | 111.4M | 88.8M | 87.2M | 84.6M | 72.9M | 67.3M | 63.5M |

### Income Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $659K | $506K | $443K | $707K | $763K | $489K | $391K | $555K |
| Cost of Revenue | $291K | $237K | $206K | $258K | $296K | $208K | $164K | $231K |
| **Gross Profit** | $369K | $269K | $238K | $450K | $468K | $283K | $227K | $325K |
| Research & Development | $93K | $79K | $74K | $86K | $73K | $91K | $81K | $71K |
| Selling, General & Admin | $779K | $708K | $847K | $743K | $731K | $776K | $871K | $881K |
| Total Operating Expenses | $872K | $787K | $921K | $829K | $804K | $867K | $952K | $952K |
| **Operating Income** | -$503K | -$518K | -$683K | -$379K | -$336K | -$584K | -$725K | -$627K |
| **EBITDA** | -$502K | -- | -- | -$378K | -- | -- | -- | -- |
| Interest Expense | $106K | $106K | $101K | $94K | $89K | $78K | $70K | $62K |
| **Net Income** | -$610K | -$624K | -$785K | -$464K | -$332K | -$580K | -$798K | -$689K |
| Basic EPS | -- | -$0.01 | -$0.01 | $0.00 | -- | -$0.01 | -$0.01 | -$0.01 |
| **Diluted EPS** | -- | -$0.01 | -$0.01 | $0.00 | -- | -$0.01 | -$0.01 | -$0.01 |
| Basic Shares Outstanding | -- | 110.8M | 111.9M | 111.9M | -- | 111.9M | 111.9M | 111.9M |
| Diluted Shares Outstanding | -- | 110.8M | 111.9M | 111.9M | -- | 111.9M | 111.9M | 111.9M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $569K | $334K | $349K | $1.09M | $3.39M | $2.39M | $3.84M | $398K | $851K | $1.64M |
| **Cash & Short-Term Investments** | $569K | $334K | $349K | $1.09M | $3.39M | $2.39M | $3.84M | $398K | $851K | $1.64M |
| Accounts Receivable, Net | $334K | $474K | $298K | $285K | $201K | $368K | $1.09M | $373K | $275K | $297K |
| Inventory | $193K | $141K | $56K | $88K | $179K | $332K | $547K | $177K | $197K | $273K |
| **Total Current Assets** | $1.19M | $1.05M | $805K | $1.60M | $3.86M | $3.20M | $5.57M | $1.04M | $1.46M | $2.46M |
| Property, Plant & Equipment, Net | $8.0K | $11K | $13K | $221K | $620K | $740K | $316K | $362K | $461K | $548K |
| Intangible Assets | -- | -- | -- | -- | -- | $366K | $441K | $529K | $658K | $822K |
| **Total Non-Current Assets** | $8.0K | $11K | $13K | $221K | $620K | $1.11M | $757K | $891K | $1.12M | $1.37M |
| **Total Assets** | $1.19M | $1.06M | $818K | $1.82M | $4.48M | $4.30M | $6.32M | $1.93M | $2.58M | $3.83M |
| Accounts Payable | $820K | $784K | $601K | $422K | $488K | $593K | $1.34M | $553K | $608K | $426K |
| **Total Current Liabilities** | $4.37M | $2.11M | $733K | $532K | $575K | $970K | $1.51M | $738K | $1.28M | $2.53M |
| Long-Term Debt | $6.60M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $3.22M | $4.06M | $2.95M | $1.02M | $0 | $0 | $0 | $4.0K | $13K | $11K |
| **Total Liabilities** | $7.59M | $6.17M | $3.68M | $1.55M | $575K | $970K | $1.51M | $742K | $1.29M | $2.54M |
| **Total Debt (incl. Leases)** | $6.60M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Common Stock | $1.30M | $1.12M | $1.12M | $1.12M | $1.11M | $873K | $871K | $768K | $683K | $631K |
| Retained Earnings | -$141.5M | -$139.0M | -$136.6M | -$133.2M | -$129.3M | -$125.8M | -$123.5M | -$123.5M | -$116.9M | -$109.5M |
| **Total Stockholders' Equity** | -$6.40M | -$5.12M | -$2.86M | $272K | $3.91M | $3.33M | $4.81M | $1.19M | $1.28M | $1.29M |
| Total Equity | -$6.40M | -$5.12M | -$2.86M | $272K | $3.91M | $3.33M | $4.81M | $1.19M | $1.28M | $1.29M |

### Balance Sheet (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $569K | $983K | $198K | $434K | $334K | $540K | $202K | $346K |
| **Cash & Short-Term Investments** | $569K | $983K | $198K | $434K | $334K | $540K | $202K | $346K |
| Accounts Receivable, Net | $334K | $242K | $252K | $389K | $474K | $287K | $180K | $371K |
| Inventory | $193K | $232K | $244K | $237K | $141K | $131K | $75K | $72K |
| **Total Current Assets** | $1.19M | $1.55M | $779K | $1.18M | $1.05M | $1.05M | $562K | $911K |
| Property, Plant & Equipment, Net | $8.0K | $9.0K | $9.0K | $10K | $11K | $11K | $12K | $13K |
| **Total Non-Current Assets** | $8.0K | $9.0K | $9.0K | $10K | $11K | $11K | $12K | $13K |
| **Total Assets** | $1.19M | $1.56M | $788K | $1.19M | $1.06M | $1.06M | $574K | $924K |
| Accounts Payable | $820K | $719K | $767K | $879K | $784K | $799K | $700K | $718K |
| **Total Current Liabilities** | $4.37M | $3.65M | $3.06M | $3.16M | $2.11M | $972K | $866K | $911K |
| Long-Term Debt | $6.60M | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $3.22M | $3.74M | $4.01M | $3.57M | $4.06M | $4.90M | $3.98M | $3.51M |
| **Total Liabilities** | $7.59M | $7.40M | $7.06M | $6.73M | $6.17M | $5.87M | $4.84M | $4.42M |
| **Total Debt (incl. Leases)** | $6.60M | -- | -- | -- | -- | -- | -- | -- |
| Common Stock | $1.30M | $1.30M | $1.12M | $1.12M | $1.12M | $1.12M | $1.12M | $1.12M |
| Retained Earnings | -$141.5M | -$140.9M | -$140.2M | -$139.5M | -$139.0M | -$138.7M | -$138.1M | -$137.3M |
| **Total Stockholders' Equity** | -$6.40M | -$5.84M | -$6.27M | -$5.55M | -$5.12M | -$4.81M | -$4.27M | -$3.50M |
| Total Equity | -$6.40M | -$5.84M | -$6.27M | -$5.55M | -$5.12M | -$4.81M | -$4.27M | -$3.50M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.48M | -$2.40M | -$3.35M | -$3.96M | -$3.49M | -$2.32M | $4.0K | -$6.55M | -$7.44M | -$6.26M |
| Depreciation & Amortization | $3.0K | $2.0K | $148K | $117K | $213K | $172K | $192K | $241K | $285K | $276K |
| Stock-Based Compensation | $197K | $147K | $214K | $324K | $567K | $841K | $787K | $2.45M | $2.36M | $1.07M |
| Change in Receivables | $140K | -$176K | -$13K | -$84K | $167K | $721K | -$716K | -$98K | $22K | -$34K |
| Change in Inventory | -$52K | -$85K | $32K | $57K | $78K | $65K | -$370K | $20K | $37K | $27K |
| **Operating Cash Flow** | -$1.74M | -$2.02M | -$2.53M | -$3.28M | -$2.42M | -$1.17M | $669K | -$2.99M | -$3.89M | -$4.56M |
| Capital Expenditure | -- | -- | -- | -$33K | -$81K | -$521K | -$58K | -$7.0K | -$19K | -$206K |
| **Free Cash Flow** | -- | -- | -- | -$3.31M | -$2.50M | -$1.69M | $611K | -$3.00M | -$3.91M | -$4.77M |
| **Investing Cash Flow** | -- | -- | -- | -$33K | -$81K | -$521K | -$58K | -$13K | -$34K | -$226K |
| Common Stock Issued | -- | -- | -- | -- | $3.50M | -- | $2.83M | $1.71M | -- | $1.05M |
| **Financing Cash Flow** | $1.97M | $2.00M | $1.78M | $1.01M | $3.50M | $239K | $2.83M | $2.55M | $3.13M | $1.23M |
| **Net Change in Cash** | $235K | -$15K | -$746K | -$2.30M | $1.00M | -$1.45M | $3.44M | -$453K | -$789K | -$3.55M |

### Cash Flow Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$610K | -$624K | -$785K | -$464K | -$332K | -$580K | -$798K | -$689K |
| Depreciation & Amortization | $1.0K | -- | -- | $1.0K | -- | -- | -- | -- |
| Stock-Based Compensation | $50K | $55K | $58K | $34K | $30K | $33K | $27K | $57K |
| Change in Receivables | -$92K | $10K | $137K | $85K | -$187K | -$107K | $191K | -$73K |
| Change in Inventory | $39K | $12K | -$7.0K | -$96K | -$10K | -$56K | -$3.0K | -$16K |
| **Operating Cash Flow** | -$414K | -$468K | -$606K | -$250K | -$456K | -$512K | -$544K | -$503K |
| **Financing Cash Flow** | $0 | $1.25M | $370K | $350K | $250K | $850K | $400K | $500K |
| **Net Change in Cash** | -$414K | $785K | -$236K | $100K | -$206K | $338K | -$144K | -$3.0K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 57.3% | 59.3% | 58.9% | 51.9% | 55.2% | 56.1% | 58.1% | 61.9% | 57.0% | 58.5% |
| **Operating Margin** | -90.0% | -103.4% | -163.2% | -210.7% | -205.4% | -62.5% | 0.1% | -292.8% | -397.0% | -328.1% |
| **Net Profit Margin** | -107.3% | -109.1% | -171.4% | -211.7% | -192.6% | -62.7% | 0.1% | -343.3% | -419.5% | -342.1% |
| Return on Equity (ROE) | -- | -- | -- | -1456.2% | -89.3% | -69.6% | 0.1% | -550.8% | -581.0% | -485.5% |
| Return on Assets (ROA) | -208.1% | -226.7% | -409.5% | -217.0% | -77.9% | -53.9% | 0.1% | -339.2% | -289.0% | -163.6% |
| Current Ratio | 0.27x | 0.50x | 1.10x | 3.02x | 6.72x | 3.30x | 3.68x | 1.41x | 1.14x | 0.97x |
| Quick Ratio | 0.23x | 0.43x | 1.02x | 2.85x | 6.41x | 2.95x | 3.32x | 1.17x | 0.98x | 0.86x |
| **Revenue Growth (YoY)** | +5.3% | +12.4% | +4.5% | +3.2% | -51.0% | -46.5% | +262.3% | +7.6% | -3.1% | +42.0% |
| Gross Profit Growth (YoY) | +1.8% | +13.1% | +18.6% | -2.9% | -51.8% | -48.4% | +240.5% | +16.8% | -5.6% | +26.3% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -57875.0% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -58075.0% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -274.4% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -376.3% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -53.1% | -76.6% | -33.3% | -36.3% | -29.2% | +87.0% | +358.8% | +22.0% | -65.1% | -97.5% |
| 10Y Revenue / Share Growth | -12.4% | +7.1% | -18.6% | -77.8% | -98.2% | -94.7% | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -44176.4% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 57.3% | 58.9% | 59.9% | 60.8% | 59.3% | 58.2% | 58.4% | 57.8% |
| **Operating Margin** | -90.0% | -79.2% | -82.5% | -86.1% | -103.4% | -138.2% | -154.4% | -173.4% |
| **Net Profit Margin** | -107.3% | -91.2% | -90.0% | -92.5% | -109.1% | -148.0% | -166.8% | -184.4% |
| Return on Assets (ROA) | -208.1% | -141.5% | -274.2% | -183.3% | -226.7% | -267.1% | -540.1% | -357.6% |
| Current Ratio | 0.27x | 0.42x | 0.25x | 0.37x | 0.50x | 1.08x | 0.65x | 1.00x |
| Quick Ratio | 0.23x | 0.36x | 0.18x | 0.30x | 0.43x | 0.94x | 0.56x | 0.92x |
| **Revenue Growth (YoY)** | -13.6% | +3.5% | +13.3% | +27.4% | +61.7% | +11.1% | +20.3% | -22.7% |
| Gross Profit Growth (YoY) | -21.2% | -4.9% | +4.8% | +38.5% | +70.2% | +9.7% | +28.2% | -26.5% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
